Search

Novozymes A-S (Class B)

Închisă

0

Rezumat

Modificarea prețului

24h

Curent

Minim

Maxim

Indicatori cheie

By Trading Economics

Venit

-15M

123M

Vânzări

-7B

997M

P/E

Medie Sector

38.009

34.212

EPS

3.36

Randament dividend

0.24

Marjă de profit

12.322

Angajați

10,933

EBITDA

-440M

2B

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+22.59% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.24%

2.88%

Următoarele câștiguri

5 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-15B

165B

Deschiderea anterioară

0

Închiderea anterioară

0

Novozymes A-S (Class B) Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

15 mar. 2026, 21:14 UTC

Evenimente importante

Week Ahead for FX, Bonds: Central Bank Decisions -2-

15 mar. 2026, 21:14 UTC

Evenimente importante

Week Ahead for FX, Bonds: Central Bank Decisions in Focus After Jump in Energy Prices

16 mar. 2026, 00:00 UTC

Evenimente importante

Hack on U.S. Medical Company Shows Reach of Iran's Cyber Capabilities -- WSJ

15 mar. 2026, 23:45 UTC

Market Talk

Nikkei May Decline on Concerns About Prolonged Middle East Conflict -- Market Talk

15 mar. 2026, 23:44 UTC

Market Talk
Evenimente importante

Gold Falls as Rising Energy Prices Exacerbate Inflation Worries -- Market Talk

15 mar. 2026, 23:35 UTC

Market Talk
Evenimente importante

Oil Futures Rise on Supply Disruption Concerns -- Market Talk

15 mar. 2026, 23:00 UTC

Achiziții, Fuziuni, Preluări

Micron Completes Acquisition Of PSMC's Tongluo P5 Site In Taiwan >MU

15 mar. 2026, 22:37 UTC

Market Talk

March Rate Hike Would Distance RBA From Government's May Budget -- Market Talk

15 mar. 2026, 22:18 UTC

Market Talk

RBA's Likely Hike Motivated By Inflation, Not Middle East -- Market Talk

15 mar. 2026, 22:14 UTC

Câștiguri

Genscript Biotech 2025 Adj Net $230.35M Vs. Adj Net $59.83M>1548.HK

15 mar. 2026, 22:14 UTC

Câștiguri

Genscript Biotech: 2025 Loss Due to High Base Effect, One-off Unrealized Gains Seen Last Year >1548.HK

15 mar. 2026, 22:14 UTC

Câștiguri

Genscript Biotech 2025 Rev $959.53M Vs. $594.49M >1548.HK

15 mar. 2026, 22:14 UTC

Câștiguri

Genscript Biotech 2025 Loss $532.83M Vs. Net $2.96B >1548.HK

15 mar. 2026, 22:14 UTC

Câștiguri

Genscript Biotech: 2025 Rev Supported by Substantial Increase in License Revenue>1548.HK

15 mar. 2026, 22:00 UTC

Evenimente importante

Oil Industry Warns Trump Administration Energy Crisis Will Likely Worsen -- WSJ

15 mar. 2026, 22:00 UTC

Evenimente importante

Oil Industry Warns Trump Administration Energy Crisis Will Likely Worsen -- WSJ

15 mar. 2026, 03:00 UTC

Evenimente importante

For Xi, Iran War Reinforces View of U.S. as Dangerous Superpower -- WSJ

14 mar. 2026, 15:00 UTC

Evenimente importante

Iran War Delivers Windfall to America's Oil Country -- WSJ

14 mar. 2026, 02:03 UTC

Câștiguri

This Copper Stock Is Worth Mining for Profits -- Barrons.com

14 mar. 2026, 01:32 UTC

Achiziții, Fuziuni, Preluări

Bill Ackman's Pershing Square IPO Is Back On -- Barrons.com

14 mar. 2026, 00:29 UTC

Achiziții, Fuziuni, Preluări

13D Filings -- Barrons.com

13 mar. 2026, 22:27 UTC

Market Talk
Evenimente importante

Bahrain Faces Uncertainty But Has Support Amid War, S&P Says -- Market Talk

13 mar. 2026, 22:13 UTC

Market Talk
Evenimente importante

Saudi Arabia Seen as Able to Weather Iran Conflict, S&P Says -- Market Talk

13 mar. 2026, 22:04 UTC

Market Talk
Evenimente importante

Emirate of RAK Outlook Stable Despite Iran War, S&P Says -- Market Talk

13 mar. 2026, 22:00 UTC

Achiziții, Fuziuni, Preluări

Trump Administration Set to Receive $10 Billion Fee for Brokering TikTok Deal -- WSJ

13 mar. 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

13 mar. 2026, 20:50 UTC

Market Talk
Evenimente importante

Financial Services Roundup: Market Talk

13 mar. 2026, 20:02 UTC

Market Talk

Canada Rate Hike in 2026 Would Mark 'Extraordinarily Bad' Policy -- Market Talk

13 mar. 2026, 19:50 UTC

Market Talk
Evenimente importante

Oil Posts Weekly Gains As Middle East Conflict Drags On -- Market Talk

13 mar. 2026, 19:35 UTC

Evenimente importante

Oil Prices Hover Near $100. India Asks Iran to Allow 23 Tankers Through Strait of Hormuz. -- Barrons.com

Novozymes A-S (Class B) Așteptări

Obiectiv de preț

By TipRanks

22.59% sus

Prognoză pe 12 luni

Medie 400 DKK  22.59%

Maxim 520 DKK

Minim 300 DKK

În baza a 3 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruNovozymes A-S (Class B) - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

3 ratings

1

Cumpărare

1

Păstrare

1

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Novozymes A-S (Class B)

Novonesis A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, microbial and medical cleaning services. Further, it provides corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions, comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, education, wastewater, and sewage sludge, and renewable diesel solutions; agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, diagnostics, enzyme, and biogas solutions. Furthermore, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novonesis A/S was founded in 1925 and is based in Bagsvaerd, Denmark.
help-icon Live chat